{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T15:20:01Z","timestamp":1706887201156},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.jviromet.2012.10.018","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T21:31:28Z","timestamp":1352928688000},"page":"314-320","source":"Crossref","is-referenced-by-count":12,"title":["Low abundance drug resistance variants in transmitted HIV drug resistance surveillance specimens identified using tagged pooled pyrosequencing"],"prefix":"10.1016","volume":"187","author":[{"given":"Hezhao","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Van Domselaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morag","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriet","family":"Merks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Sandstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2012.10.018_bib0005","doi-asserted-by":"crossref","first-page":"e2836","DOI":"10.1371\/journal.pone.0002836","article-title":"Comparative analysis of human gut microbiota by barcoded pyrosequencing","volume":"3","author":"Andersson","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2012.10.018_bib0010","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00002030-200107270-00006","article-title":"Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults","volume":"15","author":"Bartlett","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2012.10.018_bib0015","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/JCM.40.4.1413-1419.2002","article-title":"Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors","volume":"40","author":"Beck","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0020","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QCO.0b013e3280109ff1","article-title":"The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world","volume":"19","author":"Bennett","year":"2006","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.jviromet.2012.10.018_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350801302S03","article-title":"The World Health Organization's global strategy for prevention and assessment of HIV drug resistance","volume":"13","author":"Bennett","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0030","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"Bennett","year":"2009","journal-title":"PLoS ONE"},{"issue":"Suppl. 2","key":"10.1016\/j.jviromet.2012.10.018_bib0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350801302S04","article-title":"Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment","volume":"13","author":"Bennett","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0040","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.1105688108","article-title":"Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine","volume":"108","author":"Boltz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0045","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jac\/dkm082","article-title":"Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection","volume":"59","author":"Booth","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0050","first-page":"407","article-title":"Highly active antiretroviral therapy for HIV infection: lessons for the future","volume":"62","author":"Burger","year":"2004","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/135965350400900505","article-title":"Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems","volume":"9","author":"De","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0166-0934(98)00100-1","article-title":"Interlaboratory concordance of DNA sequence analysis to detect reverse transcriptase mutations in HIV-1 proviral DNA. ACTG Sequencing Working Group. AIDS Clinical Trials Group","volume":"75","author":"Demeter","year":"1998","journal-title":"J. Virol. Methods."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0065","doi-asserted-by":"crossref","first-page":"e36494","DOI":"10.1371\/journal.pone.0036494","article-title":"Low-cost ultra-wide genotyping using Roche\/454 pyrosequencing for surveillance of HIV drug resistance","volume":"7","author":"Dudley","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2012.10.018_bib0070","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/655397","article-title":"Minority variants of drug-resistant HIV","volume":"202","author":"Gianella","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0075","first-page":"672","article-title":"Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment-experienced patients","volume":"201","author":"Halvas","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0080","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/nar\/gkm435","article-title":"DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations","volume":"35","author":"Hoffmann","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0085","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3851\/IMP1839","article-title":"Next-generation sequencing of dried blood spot specimens: a novel approach to HIV drug-resistance surveillance","volume":"16","author":"Ji","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0090","doi-asserted-by":"crossref","first-page":"e9263","DOI":"10.1371\/journal.pone.0009263","article-title":"HIV drug resistance surveillance using pooled pyrosequencing","volume":"5","author":"Ji","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2012.10.018_bib0095","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1371\/journal.pone.0000638","article-title":"Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations","volume":"2","author":"Johnson","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2012.10.018_bib0100","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1371\/journal.pmed.0050158","article-title":"Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy","volume":"5","author":"Johnson","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002030-199102000-00002","article-title":"Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes","volume":"5","author":"Larder","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2012.10.018_bib0110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature03959","article-title":"Genome sequencing in microfabricated high-density picolitre reactors","volume":"437","author":"Margulies","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2012.10.018_bib0115","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/379215","article-title":"Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions","volume":"188","author":"Metzner","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/595703","article-title":"Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients","volume":"48","author":"Metzner","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0125","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1097\/01.aids.0000189878.97480.ed","article-title":"Detection of minor populations of drug-resistant HIV-1 in acute seroconverters","volume":"19","author":"Metzner","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jviromet.2012.10.018_bib0130","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/01.qai.0000214805.52723.c1","article-title":"Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing","volume":"41","author":"Oette","year":"2006","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0135","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0140","first-page":"662","article-title":"Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure","volume":"201","author":"Paredes","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-4690-6-15","article-title":"Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations","volume":"6","author":"Rozera","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.jviromet.2012.10.018_bib0150","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1128\/JCM.37.7.2291-2296.1999","article-title":"Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase","volume":"37","author":"Schuurman","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0155","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nbt1486","article-title":"Next-generation DNA sequencing","volume":"26","author":"Shendure","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0160","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/596736","article-title":"Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes","volume":"199","author":"Simen","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0165","unstructured":"Sequencing Technical Bulletin No. 005-2009. Using Multiplex Identifier (MID) Adaptors for the GS FLX Titanium Chemistry\u2014Extended MID Set. 2009."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0170","unstructured":"Sequencing Technical Bulletin No. 013-2009. Amplicon Fusion Primer Design Guidelines for GS FLX Titanium Series Lib-A Chemistry. 2009."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0175","unstructured":"UNAIDS. AIDS epidemic update\u2014December 2009. 2010."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0180","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/QCO.0b013e32833ff1e6","article-title":"The risk of HIV drug resistance following implementation of pre-exposure prophylaxis","volume":"23","author":"van d.","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/135965350200700206","article-title":"A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients","volume":"7","author":"Van","year":"2002","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/505147","article-title":"The survival benefits of AIDS treatment in the United States","volume":"194","author":"Walensky","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0195","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1101\/gr.6468307","article-title":"Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance","volume":"17","author":"Wang","year":"2007","journal-title":"Genome Res."},{"key":"10.1016\/j.jviromet.2012.10.018_bib0200","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1073\/pnas.0812600106","article-title":"Human gut microbiota in obesity and after gastric bypass","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093412003825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093412003825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T20:02:08Z","timestamp":1687809728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093412003825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0166093412003825"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2012.10.018","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}